Polysaccharides from Ganoderma lucidum attenuate cognitive impairment in 5xFAD mice by inhibiting oxidative stress

Xiaoqin Liu1, Yanbing Li2, Jiwei Wang2

  • 1Institute of Brain Science, Medical School, Shanxi Datong University, Datong, 037009, China.

PubMed

Insights

Ganoderma lucidum spores extract (GLPS) improves cognitive function in Alzheimer's disease (AD) models by reducing oxidative stress and normalizing mitochondrial dynamics. GLPS activates the Nrf2 pathway, enhancing antioxidant defenses for neuroprotection.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Biochemistry

Background:

  • Oxidative stress and imbalanced mitochondrial dynamics are central to Alzheimer's disease (AD) pathogenesis.
  • Ganoderma lucidum spores (GLPS) possess antioxidant and anti-inflammatory properties, but their role in AD neuroprotection is unclear.
  • Understanding GLPS's mechanisms in regulating oxidative stress and mitochondrial function in AD is crucial.

Purpose of the Study:

  • To investigate the neuroprotective mechanisms of GLPS on cognitive dysfunction in a mouse model of Alzheimer's disease (5x FAD mice).
  • To explore GLPS's effects on oxidative stress markers and mitochondrial dynamics in the 5x FAD mouse model.
  • To elucidate the molecular pathways, specifically Nrf2 activation, underlying GLPS's therapeutic potential.

Main Methods:

  • 5x FAD mice and wild-type (WT) C57BL/6 mice were used. 5x FAD mice were divided into AD and AD + GLPS groups.
  • GLPS (25 mg/kg) was administered via intraperitoneal injection daily for two months to the AD + GLPS group.
  • Cognitive function, amyloid-beta (Aβ) and phosphorylated tau (p-tau) levels, oxidative stress markers (SOD, MDA), mitochondrial dynamics proteins (p-Drp1, Fis1, Mfn1, Mfn2, OPA1), and Nrf2 pathway components (HO-1, NQO1, SOD2) were assessed.

Main Results:

  • GLPS treatment significantly improved cognitive function in 5x FAD mice.
  • GLPS reduced levels of p-tau and Aβ, alleviated oxidative stress (increased SOD, decreased MDA), and inhibited mitochondrial fragmentation (decreased p-Drp1, Fis1; increased Mfn1, Mfn2, OPA1).
  • GLPS activated the Nrf2 pathway, upregulating antioxidant enzymes HO-1, NQO1, and SOD2.

Conclusions:

  • GLPS demonstrates significant neuroprotective effects against cognitive deficits in the 5x FAD mouse model.
  • GLPS ameliorates AD pathology by mitigating oxidative stress and normalizing mitochondrial dynamics.
  • The therapeutic benefits of GLPS are mediated through the activation of the Nrf2-dependent antioxidant pathway.